about
Structural and Functional Analysis of the Pro-Domain of Human Cathelicidin, LL-37Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin diseaseChronic Ethanol Exposure Effects on Vitamin D Levels Among Subjects with Alcohol Use DisorderUltrashort cationic lipopeptides and lipopeptoids selectively induce cytokine production in macrophagesThe pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells.Human antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: a laboratory study.Development of a novel antimicrobial peptide, AG-30, with angiogenic properties.Comparative efficacy analysis of anti-microbial peptides, LL-37 and indolicidin upon conjugation with CNT, in human monocytesAntimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37.Recent advances in the understanding and management of rosacea.Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residuesWill new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?Pathogenic nontuberculous mycobacteria resist and inactivate cathelicidin: implication of a novel role for polar mycobacterial lipidsProtective effect of in ovo treatment with the chicken cathelicidin analog D-CATH-2 against avian pathogenic E. coliAugmentation of epithelial resistance to invading bacteria by using mRNA transfections.Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gelRole of urinary cathelicidin LL-37 and human β-defensin 1 in uncomplicated Escherichia coli urinary tract infections.Antimicrobial peptides important in innate immunity.Human cathelicidin LL-37 prevents bacterial biofilm formation.Online monitoring of metabolism and morphology of peptide-treated neuroblastoma cancer cells and keratinocytes.Determination of the antibacterial and lipopolysaccharide-neutralizing regions of guinea pig neutrophil cathelicidin peptide CAP11.Permeabilization of fungal hyphae by the plant defensin NaD1 occurs through a cell wall-dependent process.Membrane Core-Specific Antimicrobial Action of Cathelicidin LL-37 Peptide Switches Between Pore and Nanofibre Formation.Doxycycline indirectly inhibits proteolytic activation of tryptic kallikrein-related peptidases and activation of cathelicidin.Counter-ion effect on antistaphylococcal activity and cytotoxicity of selected antimicrobial peptides.
P2860
Q27676356-B00FAF9E-F4D6-4A88-ABBA-40FDCE676FB4Q28266421-0FF99115-144C-4C61-9A27-098BCC8A5802Q28392229-FE425EFD-0AEF-4D30-92BE-1EF11A0D4888Q28485935-E49612D1-7FB5-4F0A-A005-36333A512AF9Q30486489-D278B499-BE6D-44B0-B323-BF81245ED092Q33267198-CB977E1E-8C97-4F58-A94E-B5F782B57E22Q33328109-2EDBD5F0-0092-4383-98FC-42788156DCA0Q33792343-1AC06596-F23B-4E37-AD35-4C23D152F201Q33883780-90680B28-BBD2-44EB-96A0-0DE53BD25CB6Q33942083-F70E9E42-1881-47AA-9699-B120FF633F2BQ34526677-C3CBBF6D-7E51-4875-B5AF-40C492E38AE9Q35173769-F873A134-E946-470C-B068-22068A58FD54Q35620722-677BBE2B-19BF-46FE-9966-635B7AE4E0B6Q36941335-D45284A9-70ED-4B1E-B6F1-4150D4B6DEBBQ37264851-C9C38244-DA81-4C78-848E-28979405C1BDQ37542502-7A30B553-A1DF-4497-9871-16D6E0284884Q37713225-CFCCBFB8-D8B5-43C3-966A-D48BECD7F62CQ37919159-60198CA2-394D-4576-B253-D4606ABABBA0Q38037192-2008EE2E-29FE-4F70-8674-9E00A0501D83Q39530133-0AE57E37-949F-4522-8244-5712DD7D47E2Q40251093-B5C6CF02-6187-470A-BD5C-943C7316C79FQ41714058-9B384FCF-8DEC-4BD2-9E5B-11972D54D7A3Q41852119-0CB38545-9512-4C38-B758-3F8195EA817AQ42906891-BDFCCFDC-5991-40B3-9B7F-D42C26A6874FQ47728646-619957DF-2633-4346-A7B2-EF79E94EC938
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Anti-microbial activity of human CAP18 peptides.
@en
Anti-microbial activity of human CAP18 peptides.
@nl
type
label
Anti-microbial activity of human CAP18 peptides.
@en
Anti-microbial activity of human CAP18 peptides.
@nl
prefLabel
Anti-microbial activity of human CAP18 peptides.
@en
Anti-microbial activity of human CAP18 peptides.
@nl
P2093
P1476
Anti-microbial activity of human CAP18 peptides.
@en
P2093
P356
10.1016/1380-2933(95)00006-2
P577
1995-05-01T00:00:00Z